Chemoembolization of hepatocellular carcinoma (Q34922680)

5 August 2017

1 reference

title

Chemoembolization of hepatocellular carcinoma. (English)

1 reference

5 August 2017

Douglas E Ramsey

1

1 reference

5 August 2017

Lily Y Kernagis

series ordinal

2

1 reference

5 August 2017

Michael C Soulen

series ordinal

3

1 reference

5 August 2017

Jean-Francois H Geschwind

series ordinal

4

1 reference

5 August 2017

publication date

1 September 2002

1 reference

Journal of Vascular and Interventional Radiology

5 August 2017

published in

1 reference

5 August 2017

volume

13

1 reference

5 August 2017

issue

9 Pt 2

1 reference

5 August 2017

page(s)

S211-21

1 reference

Liver resections in cirrhotic patients: a Western experience

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Glucose catabolism in cancer cells: identification and characterization of a marked activation response of the type II hexokinase gene to hypoxic conditions

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Sequential hemodynamic change in hepatocellular carcinoma and dysplastic nodules: CT angiography and pathologic correlation

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Targeting cancer chemotherapeutic agents by use of lipiodol contrast medium

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Effects of intra-arterial chemotherapy with a new lipophilic anticancer agent, estradiol-chlorambucil (KM2210), dissolved in lipiodol on experimental liver tumor in rats

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transcatheter oily chemoembolization of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

In vivo and in vitro analysis of the effectiveness of doxorubicin combined with temporary arterial occlusion in liver tumors

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Impact of multidetector CT hepatic arteriography on the planning of chemoembolization treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Intraarterial chemotherapy or chemoembolization for locally advanced and/or recurrent hepatic tumors: evaluation of the feeding artery with an interventional CT system

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transection of the oesophagus for bleeding oesophageal varices

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A new prognostic system for hepatocellular carcinoma: A retrospective study of 435 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Discrimination value of the new western prognostic system (CLIP score) for hepatocellular carcinoma in 662 Japanese patients. Cancer of the Liver Italian Program

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Unresectable hepatocellular carcinoma: analysis of prognostic factors in transcatheter management

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A prognostic index of the survival of patients with unresectable hepatocellular carcinoma after transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transarterial chemoembolization for inoperable hepatocellular carcinoma and postresection intrahepatic recurrence

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Ischemic bile duct injury as a serious complication after transarterial chemoembolization in patients with hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Liver abscess after transcatheter oily chemoembolization for hepatic tumors: incidence, predisposing factors, and clinical outcome

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Risk factors for liver abscess formation after hepatic chemoembolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatic chemoembolization: safety with portal vein thrombosis

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Radiation therapy in combination with transcatheter arterial chemoembolization for hepatocellular carcinoma with extensive portal vein involvement

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Chemoembolization of hepatic neoplasms: safety, complications, and when to worry

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Determinants of postembolization syndrome after hepatic chemoembolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Subsegmental transcatheter arterial embolization for small hepatocellular carcinomas: local therapeutic effect and 5-year survival rate

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Primary treatment of hepatocellular carcinoma by arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatocellular Carcinoma: Update on Diagnosis and Treatment

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Arterial chemoembolization before liver transplantation in patients with hepatocellular carcinoma: marked tumor necrosis, but no survival benefit?

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Effect of preoperative radiological treatment of hepatocellular carcinoma before liver transplantation: a retrospective study

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A comparison of lipiodol chemoembolization and conservative treatment for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Effects of preoperative transcatheter hepatic arterial chemoembolization for hepatocellular carcinoma. The relationship between postoperative course and tumor necrosis

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transcatheter arterial chemoembolization for hepatocellular carcinoma in patients with cirrhosis: evaluation of damage to nontumorous liver tissue-long-term prospective study

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A prospective longitudinal study of quality of life after resection of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Quality-of-life assessment in palliative care

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Quality of life in palliative cancer care: results from a cluster randomized trial.

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Improving cancer care at the end of life

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Efficacy of transarterial targeted treatments on survival of patients with hepatocellular carcinoma. An Italian experience

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Prognosis of hepatocellular carcinoma smaller than 5 cm in relation to treatment: study of 100 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transcatheter oily chemoembolization for hepatocellular carcinoma. A 4-year study of 127 French patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Evaluation of transcatheter arterial embolization with epirubicin-lipiodol emulsion for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Prognostic factors in the treatment of hepatocellular carcinoma with transcatheter arterial embolization and arterial infusion

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Treatment of unresectable hepatocellular carcinoma with lipiodol chemoembolization: a multicenter randomized trial. Groupe CHC

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatic arterial embolization in patients with unresectable hepatocellular carcinoma--a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A randomized trial of intrahepatic arterial infusion of 4'-epidoxorubicin with Lipiodol versus 4'-epidoxorubicin alone in the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Prospective and randomized clinical trial for the treatment of hepatocellular carcinoma--a comparison of lipiodol-transcatheter arterial embolization with and without adriamycin (first cooperative study). The Cooperative Study Group for Liver Cancer

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transcatheter arterial embolization with or without cisplatin treatment of hepatocellular carcinoma. A randomized controlled study

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Comparison of the anticancer effect of ADMOS alone and ADMOS with CDDP in the treatment of hepatocellular carcinoma by intra-arterial injection

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Prospective and randomized controlled study of chemoembolization therapy in patients with advanced hepatocellular carcinoma. Cooperative Study Group for Liver Cancer Treatment in Shikoku area

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A prospective randomized evaluation of a compound of tegafur and uracil as an adjuvant chemotherapy for hepatocellular carcinoma treated with transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Treatment of hepatocellular carcinoma: a systematic review of randomized controlled trials

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Randomized control trials on chemoembolization for hepatocellular carcinoma: is there room for new studies?

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transarterial embolization versus symptomatic treatment in patients with advanced hepatocellular carcinoma: results of a randomized, controlled trial in a single institution.

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

A randomized trial of hepatic arterial chemoembolization in patients with unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Randomised trial of targeted chemotherapy with lipiodol and 5-epidoxorubicin compared with symptomatic treatment for hepatoma.

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Sample size estimation in phase III cancer clinical trials

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatic arterial complications in liver transplant recipients treated with pretransplantation chemoembolization for hepatocellular carcinoma.

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Percutaneous ethanol injection for the treatment of small hepatocellular carcinoma. Study of 95 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Percutaneous ethanol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Percutaneous ethanol injection therapy for hepatocellular carcinoma: results in 146 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Small hepatocellular carcinoma: percutaneous alcohol injection--results in 23 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Tumor size determines the efficacy of percutaneous ethanol injection for the treatment of small hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatocellular carcinoma: treatment with a combination therapy of transcatheter arterial embolization and percutaneous ethanol injection

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Transcatheter arterial embolization followed by percutaneous ethanol injection in the treatment of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Hepatocellular carcinoma: treatment with percutaneous ethanol injection and transcatheter arterial embolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Efficacy of combination treatment--(TAE with adriamycin and ethanol)--for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Combination therapy of transcatheter chemoembolization and percutaneous ethanol injection therapy for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Treatment of large HCC: transcatheter arterial chemoembolization combined with percutaneous ethanol injection versus repeated transcatheter arterial chemoembolization

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Survival benefit of patients with inoperable hepatocellular carcinoma treated by a combination of transarterial chemoembolization and percutaneous ethanol injection--a single-center analysis including 132 patients

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

Preoperative transcatheter arterial chemoembolization and prognosis of patients with hepatocellular carcinomas: retrospective analysis of 120 cases

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

The effect of preoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1016/S1051-0443(07)61789-8

7 January 2021

10.1016/S1051-0443(07)61789-8

Identifiers

DOI

1 reference

5 August 2017

1 reference